NASDAQ:SIEN - Sientra Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $8.45 +0.25 (+3.05 %) (As of 04/23/2019 04:00 PM ET)Previous Close$8.20Today's Range$8.1896 - $8.8652-Week Range$7.10 - $26.79Volume899,143 shsAverage Volume769,923 shsMarket Capitalization$246.84 millionP/E RatioN/ADividend YieldN/ABeta-0.08 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. It also provides body contouring products; facial and nasal implants; saline filled breast implant sizers; and miraDry System, a non-surgical device for the permanent reduction of underarm sweat, odor, and hair of all colors. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California. Receive SIEN News and Ratings via Email Sign-up to receive the latest news and ratings for SIEN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SIEN Previous Symbol CUSIPN/A CIK1551693 Webwww.sientra.com Phone805-562-3500Debt Debt-to-Equity Ratio0.42 Current Ratio2.12 Quick Ratio1.75Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$68.13 million Price / Sales3.62 Cash FlowN/A Price / Cash FlowN/A Book Value$2.34 per share Price / Book3.61Profitability EPS (Most Recent Fiscal Year)($3.25) Net Income$-82,630,000.00 Net Margins-121.28% Return on Equity-123.51% Return on Assets-52.53%Miscellaneous Employees259 Outstanding Shares29,212,000Market Cap$246.84 million Next Earnings Date5/8/2019 (Confirmed) OptionableOptionable Sientra (NASDAQ:SIEN) Frequently Asked Questions What is Sientra's stock symbol? Sientra trades on the NASDAQ under the ticker symbol "SIEN." How were Sientra's earnings last quarter? Sientra Inc (NASDAQ:SIEN) announced its quarterly earnings data on Tuesday, March, 12th. The medical instruments supplier reported ($0.86) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.67) by $0.19. The medical instruments supplier earned $19.02 million during the quarter, compared to analyst estimates of $18.87 million. Sientra had a negative net margin of 121.28% and a negative return on equity of 123.51%. View Sientra's Earnings History. When is Sientra's next earnings date? Sientra is scheduled to release their next quarterly earnings announcement on Wednesday, May 8th 2019. View Earnings Estimates for Sientra. What price target have analysts set for SIEN? 9 Wall Street analysts have issued 12 month price objectives for Sientra's shares. Their forecasts range from $9.00 to $30.00. On average, they expect Sientra's share price to reach $20.4444 in the next year. This suggests a possible upside of 141.9% from the stock's current price. View Analyst Price Targets for Sientra. What is the consensus analysts' recommendation for Sientra? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last year. There are currently 2 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sientra. Has Sientra been receiving favorable news coverage? Media coverage about SIEN stock has been trending positive recently, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Sientra earned a news impact score of 2.7 on InfoTrie's scale. They also assigned news articles about the medical instruments supplier a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. Who are some of Sientra's key competitors? Some companies that are related to Sientra include Establishment Labs (ESTA), RTI Surgical (RTIX), Invacare (IVC), ConforMIS (CFMS), Lakeland Industries (LAKE), COLLPLANT HOLDI/S (CLGN), Histogenics (HSGX), NanoVibronix (NAOV), Bionik Laboratories (BNKL), Precision Therapeutics (AIPT), Rewalk Robotics (RWLK), Wound Management Technologies (WNDM), Allied Healthcare Products (AHPI), Avitar (AVTI) and Halyard Health (HYH). What other stocks do shareholders of Sientra own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sientra investors own include Regions Financial (RF), Verizon Communications (VZ), Baidu (BIDU), ChemoCentryx (CCXI), Genocea Biosciences (GNCA), Novavax (NVAX), Allergan (AGN), Oasis Petroleum (OAS), Idera Pharmaceuticals (IDRA) and Rigel Pharmaceuticals (RIGL). Who are Sientra's key executives? Sientra's management team includes the folowing people: Mr. Jeffrey M. Nugent, Chairman & CEO (Age 72)Mr. Charles Huiner, COO and Sr. VP of Corp. Devel. & Strategy (Age 48)Mr. Keith J. Sullivan, Director & Advisor to MiraDry Bus. (Age 61)Mr. Paul Sean Little, CFO, Sr. VP & Treasurer (Age 54)Ms. Deborah Bettencourt, VP of Customer Experience & Corp. Admin. Who are Sientra's major shareholders? Sientra's stock is owned by a number of of retail and institutional investors. Top institutional investors include Virtu Financial LLC (0.06%). Company insiders that own Sientra stock include Jeffrey M Nugent, Patrick F Williams, R Scott Greer and Timothy Haines. View Institutional Ownership Trends for Sientra. Which institutional investors are buying Sientra stock? SIEN stock was acquired by a variety of institutional investors in the last quarter, including Virtu Financial LLC. Company insiders that have bought Sientra stock in the last two years include Jeffrey M Nugent, Patrick F Williams, R Scott Greer and Timothy Haines. View Insider Buying and Selling for Sientra. How do I buy shares of Sientra? Shares of SIEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Sientra's stock price today? One share of SIEN stock can currently be purchased for approximately $8.45. How big of a company is Sientra? Sientra has a market capitalization of $246.84 million and generates $68.13 million in revenue each year. The medical instruments supplier earns $-82,630,000.00 in net income (profit) each year or ($3.25) on an earnings per share basis. Sientra employs 259 workers across the globe. What is Sientra's official website? The official website for Sientra is http://www.sientra.com. How can I contact Sientra? Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier can be reached via phone at 805-562-3500 or via email at [email protected] MarketBeat Community Rating for Sientra (NASDAQ SIEN)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 190 (Vote Outperform)Underperform Votes: 226 (Vote Underperform)Total Votes: 416MarketBeat's community ratings are surveys of what our community members think about Sientra and other stocks. Vote "Outperform" if you believe SIEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SIEN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/23/2019 by MarketBeat.com StaffFeatured Article: When is a capital gain realized?